Cranbrook Wealth Management
TAK icon

Cranbrook Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Cranbrook Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23.9K Hold
1,313
– – ﹤0.01% 233
2026
Q2 		$21K Hold
1,313
– – ﹤0.01% 251
2026
Q1 		$24.3K Hold
1,313
– – ﹤0.01% 231
2025
Q4 		$20.5K Hold
1,313
– – ﹤0.01% 245
2025
Q3 		$19.2K Hold
1,313
– – ﹤0.01% 258
2025
Q2 		$20.3K Hold
1,313
– – ﹤0.01% 247
2025
Q1 		$19.5K Hold
1,313
– – ﹤0.01% 232
2024
Q4 		$17.4K Hold
1,313
– – ﹤0.01% 235
2024
Q3 		$18.7K Hold
1,313
– – ﹤0.01% 228
2024
Q2 		$17K Hold
1,313
– – ﹤0.01% 228
2024
Q1 		$18.2K Hold
1,313
– – ﹤0.01% 206
2023
Q4 		$18.7K Hold
1,313
– – 0.01% 204
2023
Q3 		$20.3K Hold
1,313
– – 0.01% 187
2023
Q2 		$20.6K Hold
1,313
– – 0.01% 194
2023
Q1 		$21.6K Hold
1,313
– – 0.01% 196
2022
Q4 		$20.5K Hold
1,313
– – 0.01% 194
2022
Q3 		$17K Hold
1,313
– – ﹤0.01% 219
2022
Q2 		$18K Hold
1,313
– – ﹤0.01% 220
2022
Q1 		$19K Hold
1,313
– – ﹤0.01% 244
2021
Q4 		$18K Hold
1,313
– – ﹤0.01% 245
2021
Q3 		$22K Hold
1,313
– – 0.01% 249
2021
Q2 		$22K Hold
1,313
– – 0.01% 236
2021
Q1 		$24K Hold
1,313
– – 0.01% 232
2020
Q4 		$24K Hold
1,313
– – 0.01% 197
2020
Q3 		$23K Hold
1,313
– – 0.01% 177
2020
Q2 		$24K Hold
1,313
– – 0.01% 170
2020
Q1 		$20K Hold
1,313
– – 0.01% 167
2019
Q4 		$26K Hold
1,313
– – 0.01% 167
2019
Q3 		$23K Hold
1,313
– – 0.01% 164
2019
Q2 		$23K Hold
1,313
– – 0.01% 162
2019
Q1 		$27K Buy
+1,313
New +$26.4K 0.01% 160

Other funds holding TAK

Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Clean Yield Group
Clean Yield Group Norwich, Vermont $412M AUM 20.54% 1-Year Est. Return
Vise Technologies
Vise Technologies New York $12B AUM 18.78% 1-Year Est. Return
Legacy Wealth Asset Management
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return
Quadrant Capital Group
Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return
Gold Investment Management
Gold Investment Management Edmonton, Alberta, Canada $358M AUM 35.31% 1-Year Est. Return
Summit Global Investments
Summit Global Investments Bountiful, Utah $2.02B AUM 17.87% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Cranbrook Wealth Management's TAK Position: Q3 2026 in Review

Cranbrook Wealth Management held its Takeda Pharmaceutical (TAK) position steady in Q3 2026 at 1,313 shares worth $23.9K. The position accounts for ﹤0.01% of the portfolio, ranked #233.

Cranbrook Wealth Management first reported a position in TAK in Q1 2019 and has held it in 31 quarters since. The position peaked at $27K in Q1 2019. 131 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Cranbrook Wealth Management held 1,313 shares of Takeda Pharmaceutical worth $23.9K as of Q3 2026.
  • Cranbrook Wealth Management left its Takeda Pharmaceutical share count unchanged in Q3 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Cranbrook Wealth Management's portfolio in Q3 2026, its #233 holding.
  • Cranbrook Wealth Management first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 31 quarters since.
  • Cranbrook Wealth Management's Takeda Pharmaceutical position peaked at $27K in Q1 2019.
  • 131 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Cranbrook Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.